Skip to content
healthcare.dev

oxcarbazepine

NDC 68382-691, oxcarbazepine, tablet, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
68382-691
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211747
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-691 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE150 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
68382-691-0168382069101100 TABLET in 1 BOTTLE (68382-691-01)
68382-691-0568382069105500 TABLET in 1 BOTTLE (68382-691-05)
68382-691-306838206913010 BLISTER PACK in 1 CARTON (68382-691-30) / 10 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5048dc87-2d89-434d-be51-4a97b0ce0601

Use it

Look up 68382-691 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-691 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-691. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.